Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rechziegler

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Fortschritte Der Medizin|May 3, 1984
[Non-steroid antirheumatic agents. Criteria for a rational selection]H Rechziegler
Current Medical Research and Opinion|January 1, 1985
Acemetacin in the treatment of rheumatic diseases: an open, multi-centre trialH Rechziegler, P Zündorf
Medizinische Klinik (Munich, Germany : 1983)|May 15, 1990
[Clinical profile of acemetacin]H Rechziegler, R Thebud-Lassak
Arzneimittel-Forschung|January 1, 1980
[Multicentre long-term study with acemetacin (author's transl)]W Blumberger, H Rechziegler, H Spechtmeyer
Zeitschrift Fur Rheumatologie|July 1, 1987
[Interactions of non-steroidal antirheumatic drugs with oral antidiabetic agents: acemetacin--glibenclamide]E Haupt, F K Hoppe, H Rechziegler, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Fortschritte Der Medizin|May 3, 1984
[Non-steroid antirheumatic agents. Criteria for a rational selection]H Rechziegler
Current Medical Research and Opinion|January 1, 1985
Acemetacin in the treatment of rheumatic diseases: an open, multi-centre trialH Rechziegler, P Zündorf
Medizinische Klinik (Munich, Germany : 1983)|May 15, 1990
[Clinical profile of acemetacin]H Rechziegler, R Thebud-Lassak
Arzneimittel-Forschung|January 1, 1980
[Multicentre long-term study with acemetacin (author's transl)]W Blumberger, H Rechziegler, H Spechtmeyer
Zeitschrift Fur Rheumatologie|July 1, 1987
[Interactions of non-steroidal antirheumatic drugs with oral antidiabetic agents: acemetacin--glibenclamide]E Haupt, F K Hoppe, H Rechziegler, et al.
Pageof 1